Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Therapeutic needs revive arsenic compound.

Pharmaceutical Science & Technology Today

|December 16, 2000

Summary

This summary is machine-generated.

Arsenic trioxide, once an insecticide, is now approved to treat acute promyelocytic leukaemia (APL). This rare leukaemia affects about 2000 Americans annually, offering new hope for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnosis of Infantile Diseases.

Buffalo medical and surgical journal·2023

Same author

An Account of the Publications and Experiments on the Cow-Pox; Illustrated by a Coloured Plate, Which Exhibits the Appearance of the Eruption on the Arm of a Milker on the Tenth Day of the Disease. The Pock on the Forefinger Represents the Appearance of a Vesicle before Suppuration Begins.

The Medical and physical journal·2018

Same author

Observations on Hydrophobia.

The Medical and physical journal·2018

Same author

Doped silica fibre thermoluminescence measurements of radiation dose in the use of <sup>223</sup>Ra.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2017

Same author

Metalation of a 3,5-dichloro-teritary benzamide. An unusual regioselectivity observation

The Journal of organic chemistry·2001

Same author

Parametric excitation of Alfven waves by gravitational radiation

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2001

Area of Science:

Oncology
Hematology
Toxicology

Background:

Arsenic compounds have historical uses, including as insecticides.
Acute promyelocytic leukaemia (APL) is a rare and aggressive subtype of leukaemia.
Limited treatment options previously existed for APL.

Purpose of the Study:

To report the FDA approval of Trisenox (arsenic trioxide) for APL treatment.
To highlight the significance of this new therapeutic option for a rare cancer.

Main Methods:

FDA review and approval process.
Clinical data supporting the efficacy and safety of arsenic trioxide in APL.

Main Results:

Arsenic trioxide (Trisenox) approved by the FDA on September 26, 2000.

Related Experiment Videos

Targeted treatment for acute promyelocytic leukaemia (APL).

Conclusions:

Arsenic trioxide represents a novel therapeutic agent for APL.
The approval provides a new treatment avenue for approximately 2000 APL patients in the USA annually.